The caffeoylquinic acid-rich Pandanus tectorius fruit extract increases insulin sensitivity and regulates hepatic glucose and lipid metabolism in diabetic db/db mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 4, 2014, Pages 412-419

  Wu, Chongming ^a   Zhang, Xiaopo ^a   Zhang, Xue ^a   Luan, Hong ^a   Sun, Guibo ^a   Sun, Xiaobo ^a   Wang, Xiaoliang ^b   Guo, Peng ^a   Xu, Xudong ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

AMPK; Caffeoylquinic acid; Diabetes; GLUT4; Hyperlipidemia; Pandanus tectorius fruit

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; CAFFEOYLQUINIC ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; HEXOKINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTERLEUKIN 6; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PANDANUS TECTORIUS FRUIT EXTRACT; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACT; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GLUT4 ENHANCER FACTOR, MOUSE; QUINIC ACID; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFICACY; DYSLIPIDEMIA; FRUIT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINISM; HYPERTROPHY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; LIPOGENESIS; METABOLOMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL GLUCOSE TOLERANCE TEST; PANDANUS TECTORIUS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL MEMBRANE; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; EATING; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INSULIN RESISTANCE; METABOLISM; PANDANACEAE; PHOSPHORYLATION; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BODY WEIGHT; CELL MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DNA-BINDING PROTEINS; EATING; FRUIT; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PANDANACEAE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHORYLATION; PLANT EXTRACTS; QUINIC ACID; TRANSCRIPTION FACTORS;

EID: 84896884306     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.12.002     Document Type: Article

References (33)

1. Barnett A.H. The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide. Diabetes Obes Metab 2012, 14:304-314.
2. Inzucchi S.E. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002, 287:360-372.
3. Ong K.W., Hsu A., Tan B.K. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol 2013, 85:1341-1351.
4. Erk T., Renouf M., Williamson G., Melcher R., Steiling H., Richling E. Absorption and isomerization of caffeoylquinic acids from different foods using ileostomist volunteers. Eur J Nutr 2013, 10.1007/s00394-013-0512-z.
5. Nurul Islam M., Jung H.A., Sohn H.S., Kim H.M., Choi J.S. Potent alpha-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris. Arch Pharm Res 2013, 36:542-552.
6. Matsui T., Ebuchi S., Fujise T., Abesundara K.J., Doi S., Yamada H., et al. Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caffeoylquinic acid. Biol Pharm Bull 2004, 27:1797-1803.
7. Abrahao S.A., Pereira R.G., de Sousa R.V., Lima A.R., Crema G.P., Barros B.S. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr 2013, 68:184-189.
8. Lin W.Y., Xaiver Pi-Sunyer F., Chen C.C., Davidson L.E., Liu C.S., Li T.C., et al. Coffee consumption is inversely associated with type 2 diabetes in Chinese. Eur J Clin Invest 2011, 41:659-666.
9. Herrera-Arellano A., Aguilar-Santamaria L., Garcia-Hernandez B., Nicasio-Torres P., Tortoriello J. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine 2004, 11:561-566.
10. Englberger L., Aalbersberg W., Dolodolotawake U., Schierle J., Humphries J., Iuta T., et al. Carotenoid content of pandanus fruit cultivars and other foods of the Republic of Kiribati. Public Health Nutr 2006, 9:631-643.
11. Englberger L. Are pacific islanders still enjoying the taste of pandanus?. Pacific Islands Nutrition 2003, 58:10-11.
12. Zhang X., Wu C., Wu H., Sheng L., Su Y., Luan H., et al. Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet. PLoS One 2013, 8:e61922.
13. Wu Q., Zhang C. Determining microelements in Pandanus tectorius Sol. from two different producing areas. Food Machinery 2010, 26:143-146.
14. Iizuka K., Bruick R.K., Liang G., Horton J.D., Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A 2004, 101:7281-7286.
15. Wu C., Li Y., Chen Y., Lao X., Sheng L., Dai R., et al. Hypoglycemic effect of Belamcanda chinensis leaf extract in normal and STZ-induced diabetic rats and its potential active faction. Phytomedicine 2011, 18:292-297.
16. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
17. Wu C., Feng J., Wang R., Liu H., Yang H., Rodriguez P.L., et al. HRS1 acts as a negative regulator of abscisic acid signaling to promote timely germination of Arabidopsis seeds. PLoS One 2012, 7:e35764.
18. Bertram H.C., Jeppesen P.B., Hermansen K. An NMR-based metabonomic investigation on effects of supplementation with isosteviol or soy protein to diabetic KKAy mice. Diabetes Obes Metab 2009, 11:992-995.
19. Zira A., Kostidis S., Theocharis S., Sigala F., Engelsen S.B., Andreadou I., et al. 1H NMR-based metabonomics approach in a rat model of acute liver injury and regeneration induced by CCl4 administration. Toxicology 2013, 303:115-124.
20. Collino S., Martin F., Montoliu I., Barger J.L., Silva L.D., Prolla T.A., et al. Transcriptomics and metabonomics identify essential metabolic signatures in calorie restriction (CR) regulation across multiple mouse strains. Molecules 2013, 3:881-911.
21. Treebak J.T., Glund S., Deshmukh A., Klein D.K., Long Y.C., Jensen T.E., et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 2006, 55:2051-2058.
22. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004, 53:2087-2094.
23. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
24. Dyck D.J., Heigenhauser G.J., Bruce C.R. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006, 186:5-16.
25. Finucane F.M., Luan J., Wareham N.J., Sharp S.J., O'Rahilly S., Balkau B., et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009, 52:2345-2349.
26. Gagnon J., Sheppard E., Anini Y. Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells. Diabetes Obes Metab 2013, 15:276-279.
27. Lee-Young R.S., Bonner J.S., Mayes W.H., Iwueke I., Barrick B.A., Hasenour C.M., et al. AMP-activated protein kinase (AMPK)alpha2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle. Diabetologia 2013, 56:608-617.
28. Hijmans B.S., Grefhorst A., Oosterveer M.H., Groen A.K. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. Biochimie 2014, 96:121-129.
29. Pari L., Saravanan R. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats. Diabetes Obes Metab 2004, 6:286-292.
30. Yarushkin A.A., Kachaylo E.M., Pustylnyak V.O. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N, N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4alpha and FOXO1 transcriptional activity. Br J Pharmacol 2013, 168:1923-1932.
31. Sánchez-Quesada J.L., Pérez A. Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus. Endocrinol Nutr 2013, 60:518-528.
32. Morise A., Thomas C., Landrier J.F., Besnard P., Hermier D. Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice. Eur J Nutr 2009, 48:465-473.
33. Payne V.A., Au W.S., Lowe C.E., Rahman S.M., Friedman J.E., O'Rahilly S., et al. C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis. Biochem J 2010, 425:215-223.